EverFlex™ EVD35-08-120-120Recalls & reported problems
Covidien LP · STENT EVD35-08-120-120 EF ENTRUST V01 · Class 3 · Implant
All models of EverFlex (41)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00821684051542), received between Jan 31, 2019 and Mar 1, 2021 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
3 other recalls cover devices cleared under the same FDA submission (P110023); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Detachment of Device or Device Component1
- Device Dislodged or Dislocated1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 1, 2021Activation, Positioning or Separation Problem; Detachment of Device or Device Component; Activation, Positioning or Separation Problem; Detachment of Device or Device Component
PHYSICIAN WAS ATTEMPTING TO USE EVERFLEX ENTRUST SELF-EXPANDING STENT DURING PROCEDURE TO TREAT A SEVERELY CALCIFIED LESION IN THE RIGHT POPLITEAL ARTERY. THE VESSEL WAS SEVERELY TORTUOUS. NO EMBOLIC PROTECTION WAS USED. THERE WAS NO DAMAGE NOTED TO PACKAGING. THERE WAS NO ISSUE NOTED WHEN REMOVING THE DEVICE FROM HOOP/TRAY. THE DEVICE WAS PREPPED PER IFU WITH NO ISSUES IDENTIFIED. DEPLOYMENT ISSUE OCCURRED. THE DEPLOYMENT WHEEL CRACKED AND WAS UNABLE TO COMPLETE DELIVERY USING THUMB WHEEL. THE THUMBSCREW/LOCK-PIN WAS CHECKED FOR SECUREMENT PRIOR TO PROCEDURE. THE LOCK-PIN WAS REMOVED PRIOR TO DEPLOYMENT. THE LESION WAS PRE DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY-DEPLOYED STENT. THERE WAS RESISTANCE ENCOUNTERED WHEN ADVANCING THE DEVICE. IT WAS REPORTED THAT THE STENT DEPLOYED HALFWAY BEFORE THE THUMB WHEEL CRACKED. FOLLOWING THUMB WHEEL BREAK, THE DELIVERY SYSTEM WAS WITHDRAWN FROM THE PATIENT OVER THE WIRE. AS THE SYSTEM WAS WITHDRAWN, THE STENT DELIVERED WHERE THE PHYSICIAN INTENDED. ENOUGH PURCHASE WAS MADE BY THE STENT ON THE VESSEL WALL THAT IT SELF-DEPLOYED THE REST OF THE WAY. NO MANUAL DEPLOYMENT METHOD WAS USED. PHYSICIAN MENTIONED RESISTANCE DELIVERING THE
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11391292 ↗InjuryJan 31, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
THE PHYSICIAN INTENDED TO USE AN EVERFLEX ENTRUST TO TREAT A 120MM MODERATELY CALCIFIED LESION WITH 90% STENOSIS IN THE RIGHT PROXIMAL, MID AND DISTAL EXTERNAL ILIAC OF DIAMETER 7MM. A 6FR TERUMO SHEATH AND AN 0.035 GUIDEWIRE WAS USED. NO EMBOLIC PROTECTION WAS USED. THE LESION WAS NOT PRE-DILATED. THE DEVICE WAS PREPPED WITH NO ISSUES. THE DEVICE DID PASS THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS ENCOUNTERED DURING ADVANCEMENT AND NO EXCESSIVE FORCE WAS USED. IT WAS REPORTED THAT THE STENT SEEMED TO PUSH OUT FROM THE DISTAL MARK RATHER THAN THE OUTER SHEATH RETRACTING OVER THE CATHETER. THE STENT WAS DEPLOYED INCORRECTLY AND REMAINS IN THE PATIENT. NO PATIENT INJURY WAS REPORTED.
Patient problems: Patient Problem/Medical Problem
MAUDE report 8292228 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P110023. One submission often covers many models, so check the product and lot details in each record.
- Z-0623-2024 · Nov 20, 2023 · CompletedProtege GPS Self-Expanding Peripheral Stent System, product number SERB65-09-60-80, Sterile.
- Z-1644-2022 · Jul 14, 2022 · Open, ClassifiedEverFlex Self-Expanding Peripheral Stent with Entrust Delivery System
- Z-2048-2016 · May 23, 2016 · TerminatedEV3 EverFiex" Self-expanding Peripheral Stent System, Sterilized using Ethylene Oxide, Rx Only, PRB35-08-040-080. The Protege EverFiex" Self-expanding Peripheral Stent System is a
Other STENT, SUPERFICIAL FEMORAL ARTERY devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page